BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19629500)

  • 21. Long-term follow-up status of patients with neuroblastoma after undergoing either aggressive surgery or chemotherapy--a single institutional study.
    Kubota M; Yagi M; Kanada S; Okuyama N; Kinoshita Y; Yamazaki S; Asami K; Ogawa A; Watanabe T
    J Pediatr Surg; 2004 Sep; 39(9):1328-32. PubMed ID: 15359385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case selection in minimally invasive surgical treatment of neuroblastoma.
    Boutros J; Bond M; Beaudry P; Blair GK; Skarsgard ED
    Pediatr Surg Int; 2008 Oct; 24(10):1177-80. PubMed ID: 18716783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study.
    Sung KW; Son MH; Lee SH; Yoo KH; Koo HH; Kim JY; Cho EJ; Lee SK; Choi YS; Lim DH; Kim JS; Kim DW
    Bone Marrow Transplant; 2013 Jan; 48(1):68-73. PubMed ID: 22635247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
    Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
    J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved survival of children with advanced neuroblastoma treated by intensified therapy including myeloablative chemotherapy with stem cell transplantation: a retrospective analysis from the Tohoku Neuroblastoma Study Group.
    Imaizumi M; Watanabe A; Kikuta A; Takano T; Ito E; Shimizu T; Tsuchiya S; Iinuma K; Konno T; Ohi R; Hayashi Y;
    Tohoku J Exp Med; 2001 Oct; 195(2):73-83. PubMed ID: 11846211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
    Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroblastoma in monozygotic twins with distinct presentation pathology and outcome: is it familial or in utero metastasis.
    Abu-Arja R; Hashem H; El-Sheikh A; Abusin G
    Pediatr Blood Cancer; 2014 Jun; 61(6):1124-5. PubMed ID: 24376049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stage IV-S neuroblastoma. Results with definitive therapy.
    Stokes SH; Thomas PR; Perez CA; Vietti TJ
    Cancer; 1984 May; 53(10):2083-6. PubMed ID: 6704896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term prognosis of low-risk neuroblastoma treated by surgery alone: an experience from a single institution of China.
    Yao W; Li K; Dong KR; Zheng S; Xiao XM
    World J Pediatr; 2019 Apr; 15(2):148-152. PubMed ID: 30446974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the role of surgery in 25 patients with metastatic neuroblastoma].
    Nakadate H; Kishino T; Ogawa Y; Hatayama Y; Hatae Y; Takeda T; Naitoh H; Sasaki M
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1315-20. PubMed ID: 2369136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of surgery in delayed local treatment for INSS 4 neuroblastoma.
    Uehara S; Yoneda A; Oue T; Nakahata K; Zenitani M; Miyamura T; Hashii Y; Fukuzawa M; Okuyama H
    Pediatr Int; 2017 Sep; 59(9):986-990. PubMed ID: 28643949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Features and outcome of neuroblastoma detected before birth.
    Granata C; Fagnani AM; Gambini C; Boglino C; Bagnulo S; Cecchetto G; Federici S; Inserra A; Michelazzi A; Riccipetitoni G; Rizzo A; Tamaro P; Jasonni V; De Bernardi B
    J Pediatr Surg; 2000 Jan; 35(1):88-91. PubMed ID: 10646781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multivariate analysis of risk factors for patients with stage 4 neuroblastoma who were older than 18 months at diagnosis: a report from a single institute in Shanghai, China.
    Cai J; Pan C; Tang Y; Chen J; Zhou M; Li B; Xue H; Shen S; Gao Y; Zhang A; Tang J
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1327-1335. PubMed ID: 28283783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma.
    Caruso DA; Orme LM; Amor GM; Neale AM; Radcliff FJ; Downie P; Tang ML; Ashley DM
    Cancer; 2005 Mar; 103(6):1280-91. PubMed ID: 15693021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First-line high-dose chemotherapy combined with peripheral blood stem cell transplantation for patients with advanced extragonadal germ cell tumors.
    Kumano M; Miyake H; Hara I; Furukawa J; Takenaka A; Fujisawa M
    Int J Urol; 2007 Apr; 14(4):336-8. PubMed ID: 17470166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stage IV neuroblastoma in infants. Long-term survival.
    Paul SR; Tarbell NJ; Korf B; Kretschmar CS; Lavally B; Grier HE
    Cancer; 1991 Mar; 67(6):1493-7. PubMed ID: 2001536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anaplastic large cell neuroblastoma.
    Abramowsky CR; Katzenstein HM; Alvarado CS; Shehata BM
    Pediatr Dev Pathol; 2009; 12(1):1-5. PubMed ID: 18397155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [NEUROBLASTOMA IN PEDIATRIC PATIENTS].
    Solovyov AE; Morgun VV; Paholchuk AP
    Klin Khir; 2015 Jun; (6):59-61. PubMed ID: 26521471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin.
    Kushner BH; Ostrovnaya I; Cheung IY; Kuk D; Modak S; Kramer K; Roberts SS; Basu EM; Yataghene K; Cheung NK
    Oncotarget; 2016 Jan; 7(4):4155-66. PubMed ID: 26623730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.